Your session is about to expire
← Back to Search
SBIRT-T for HIV (Human Immunodeficiency Virus) (TRUST Trial)
N/A
Waitlist Available
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
HIV uninfected
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
TRUST Trial Summary
This trial aims to use a brief intervention to reduce substance abuse in at-risk transgender women in Florida, in order to increase prevention methods for HIV.
Who is the study for?
This trial is for transgender women over the age of 18 living in South Florida who are not currently using substances as per AUDIT and SBIRT criteria, and are HIV negative. It's not open to those with hazardous alcohol or drug use or transgender women who are HIV positive.Check my eligibility
What is being tested?
The study tests an adapted brief intervention called SBIRT-T designed specifically for at-risk transgender women to prevent substance abuse and promote HIV prevention strategies like routine screening, PrEP, and nPEP uptake.See study design
What are the potential side effects?
Since this trial involves a behavioral intervention rather than medication, traditional side effects aren't expected. However, participants may experience emotional discomfort discussing sensitive topics during the sessions.
TRUST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not have HIV.
TRUST Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants with substance abuse
Secondary outcome measures
Rate of Preexposure prophylaxis (PrEP) election
TRUST Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SBIRT-TExperimental Treatment1 Intervention
The screening, brief intervention and referral to treatment (SBIRT-T) will be adapted and used as the intervention in the experimental arm
Group II: INFO-CActive Control1 Intervention
The INFO-C group is a time-matched comparison control where information will be provided on substance use and PrEP services in a non-SBIRT-T format via printed and audio-visual study material
Find a Location
Who is running the clinical trial?
University of Central FloridaLead Sponsor
78 Previous Clinical Trials
1,097,390 Total Patients Enrolled
Florida International UniversityOTHER
99 Previous Clinical Trials
17,219 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has enrollment for this trial commenced?
"The clinical trial is still open for participation, as per the data posted on clinicaltrials.gov. This investigation was launched on September 19th 2019 and last modified June 8th 2021."
Answered by AI
What is the size of this cohort under observation?
"That is correct. As per the information hosted on clinicaltrials.gov, this medical study first appeared on September 19th 2019 and has been recently updated as of June 8th 2021. 76 participants are needed from 1 sites for the trial to commence."
Answered by AI
Who else is applying?
What state do they live in?
Missouri
Florida
How old are they?
18 - 65
What site did they apply to?
University of Central Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How responsive is this trial?
Typically responds via
Email
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger